Middle East respiratory syndrome–related coronavirus

Middle East respiratory syndrome-related coronavirus (MERS-CoV) is a viral respiratory illness that was first reported in Saudi Arabia in 2012. It is caused by a coronavirus called Middle East respiratory syndrome coronavirus (MERS-CoV). Most people infected with MERS-CoV developed severe respiratory illness, including fever, cough, and shortness of breath. Many of them have died.

Symptoms

The symptoms of MERS-CoV infection include severe acute respiratory illness with fever, cough, and shortness of breath. Some people also had gastrointestinal symptoms including diarrhea and nausea/vomiting. For many people with MERS, more severe complications followed, such as pneumonia and kidney failure.

Transmission

MERS-CoV, like other coronaviruses, likely spreads from an infected person’s respiratory secretions, such as through coughing. However, the precise ways the virus spreads are not currently well understood.

Prevention

There is currently no vaccine to prevent MERS-CoV infection. The U.S. National Institutes of Health is exploring the possibility of developing one.

Treatment

There is no specific antiviral treatment recommended for MERS-CoV infection. Individuals with MERS often receive medical care to help relieve symptoms. For severe cases, current treatment includes care to support vital organ functions.

See also

• Coronavirus
• Severe acute respiratory syndrome (SARS)
• Pneumonia
• Kidney failure

Middle East respiratory syndrome–related coronavirus Resources
Latest articles Most recent articles Ongoing trials	Wikipedia